Source: centralcharts

Press Release: Arix Bioscience : Correction: Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock

Arix Bioscience PLC (ARIX) Correction: Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock 13-Nov-2023 / 16:00

Read full article »
Arix Bioscience's Competitors | Arix Bioscience's News | Arix Bioscience's Financials
Stay up-to-date with the latest news on Arix
Annual Revenue
$100K-5.0M
Employees
1-25
Robert Lyne's photo - CEO of Arix

CEO

Robert Lyne

CEO Approval Rating

85/100

Read more
Stay up-to-date with the latest news on Arix